Prognostic Factors in Periampullary Tumors and Cysts

NCT ID: NCT05155878

Last Updated: 2022-01-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-01

Study Completion Date

2040-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The project aims at analysing prognostic and predictive factors involved in diagnostics and surgical treatment of cysts and tumors in the pancreas and periampullary region using both clinical data and blood and tissue samples for biomarker development and validation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

From november 2021 an onward, study participants will be prospectively enrolled within the observational study. Before that, study participants are retrospectively enrolled. The study has a broad perspective including studies on clinical outcomes and prognostics based on patient and tumor characteristics.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreas Cancer Pancreas Neoplasm Pancreas Cyst Pancreatic Fistula Pancreas Disease Bile Duct Cancer Periampullary Cancer Surgery Surgery--Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Recommended surgery for tumor or cyst in the pancreas or periampullary region
* Information avalible in electronic journal files
* Informed consent (or deceased for retrospective part of the study)

Exclusion Criteria

* No informed consent (and still alive at study initiation)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Umeå University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Oskar Franklin

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Oskar Franklin, MD/PhD

Role: PRINCIPAL_INVESTIGATOR

Umeå University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Surgical Clinic at Umeå University Hospital

Umeå, , Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Oskar Franklin, MD/PhD

Role: CONTACT

+4690785000

Asif Halimi, MD

Role: CONTACT

+4690785000

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Oskar Franklin, PhD

Role: primary

+4690785000

Agneta Karhu

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UmU-parpanc

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.